Variant report

Variant	nsv879622
Chromosome Location	chr4:95917980-95984379
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr4:95966549-95967073	A549	lung:	n/a	n/a
2	BHLHE40	chr4:95983001-95983312	K562	blood:	n/a	n/a
3	CEBPB	chr4:95944298-95944525	A549	lung:	n/a	n/a
4	CEBPB	chr4:95921013-95921138	HepG2	liver:	n/a	chr4:95921098-95921109
5	CEBPB	chr4:95967239-95967357	A549	lung:	n/a	n/a
6	CEBPB	chr4:95920920-95921132	A549	lung:	n/a	chr4:95921098-95921109
7	CEBPB	chr4:95939943-95940491	A549	lung:	n/a	chr4:95940211-95940222
8	CEBPB	chr4:95926862-95927013	K562	blood:	n/a	chr4:95926913-95926924 chr4:95926913-95926924 chr4:95926908-95926925
9	CEBPB	chr4:95939996-95940425	A549	lung:	n/a	chr4:95940211-95940222
10	CEBPB	chr4:95964704-95964919	HepG2	liver:	n/a	chr4:95964860-95964871 chr4:95964859-95964872 chr4:95964859-95964872
11	CEBPB	chr4:95938946-95939191	HepG2	liver:	n/a	chr4:95939072-95939083
12	CEBPB	chr4:95938965-95939187	A549	lung:	n/a	chr4:95939072-95939083
13	CEBPB	chr4:95949058-95949430	ECC-1	luminal epithelium:	n/a	n/a
14	CEBPB	chr4:95944339-95944603	IMR90	lung:	n/a	n/a
15	CEBPB	chr4:95941648-95941994	A549	lung:	n/a	n/a
16	CEBPB	chr4:95949053-95949376	H1-hESC	embryonic stem cell:	n/a	n/a
17	CEBPB	chr4:95964569-95965158	A549	lung:	n/a	chr4:95964860-95964871 chr4:95964859-95964872 chr4:95964859-95964872
18	CEBPB	chr4:95942314-95942789	IMR90	lung:	n/a	chr4:95942608-95942621
19	CEBPB	chr4:95964692-95964997	A549	lung:	n/a	chr4:95964860-95964871 chr4:95964859-95964872 chr4:95964859-95964872
20	CEBPB	chr4:95937517-95937663	HepG2	liver:	n/a	n/a
21	CEBPB	chr4:95938821-95939218	MCF-7	breast:	n/a	chr4:95939072-95939083
22	CEBPB	chr4:95941595-95941936	A549	lung:	n/a	n/a
23	CEBPB	chr4:95959531-95959659	A549	lung:	n/a	n/a
24	CEBPB	chr4:95940063-95940359	A549	lung:	n/a	chr4:95940211-95940222
25	CEBPB	chr4:95942478-95942597	A549	lung:	n/a	n/a
26	CEBPB	chr4:95938833-95939290	A549	lung:	n/a	chr4:95939072-95939083
27	CREB1	chr4:95966623-95966862	A549	lung:	n/a	n/a
28	CTCF	chr4:95941780-95941930	HMF	breast:	n/a	chr4:95941812-95941828 chr4:95941811-95941829
29	CTCF	chr4:95941800-95941950	MCF-7	breast:	n/a	chr4:95941812-95941828 chr4:95941811-95941829
30	CTCF	chr4:95980940-95981090	AG10803	skin:	n/a	n/a
31	CTCF	chr4:95980900-95981170	NHDF-neo	bronchial:	n/a	n/a
32	CTCF	chr4:95941797-95941856	MCF-7	breast:	n/a	chr4:95941812-95941828 chr4:95941811-95941829
33	CTCF	chr4:95919697-95919748	GM13976	blood:	n/a	n/a
34	CTCF	chr4:95941540-95941690	A549	lung:	n/a	n/a
35	CTCF	chr4:95980920-95981070	SK-N-SH_RA	brain:	n/a	n/a
36	CTCF	chr4:95941757-95941887	K562	blood:	n/a	chr4:95941812-95941828 chr4:95941811-95941829
37	CTCF	chr4:95941700-95941850	A549	lung:	n/a	chr4:95941812-95941828 chr4:95941811-95941829
38	CTCF	chr4:95980900-95981050	BE2_C	brain:	n/a	n/a
39	CTCF	chr4:95925061-95925174	Kidney_OC	kidney:	n/a	n/a
40	CTCF	chr4:95941761-95941874	K562	blood:	n/a	chr4:95941812-95941828 chr4:95941811-95941829
41	CTCF	chr4:95931042-95931119	Hela-S3	cervix:	n/a	chr4:95931076-95931097
42	CTCF	chr4:95980900-95981050	AoAF	blood vessel:	n/a	n/a
43	CTCF	chr4:95941720-95941870	MCF-7	breast:	n/a	chr4:95941812-95941828 chr4:95941811-95941829
44	E2F4	chr4:95926585-95926785	MCF10A-Er-Src	breast:	n/a	n/a
45	EBF1	chr4:95979693-95979710	GM12878	blood:	n/a	n/a
46	ELK1	chr4:95959872-95959907	GM12878	blood:	n/a	n/a
47	EP300	chr4:95966330-95967185	A549	lung:	n/a	n/a
48	EP300	chr4:95966436-95967131	A549	lung:	n/a	n/a
49	EP300	chr4:95946761-95947264	T-47D	breast:	n/a	n/a
50	EP300	chr4:95980738-95981210	SK-N-SH_RA	brain:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:95960149-95960199	LNCaP	prostate:	n/a
2	chr4:95960149-95960199	HNPCEpiC	eye:	n/a
3	chr4:95960149-95960199	K562	blood:	n/a
4	chr4:95960149-95960199	HCT-116	colon:	n/a
5	chr4:95960149-95960199	Hepatocyte	liver:	n/a
6	chr4:95960149-95960199	HRCEpiC	kidney:	n/a
7	chr4:95960149-95960199	NHBE	bronchial:	n/a
8	chr4:95960149-95960199	MCF10A-Er-Src	breast:	n/a
9	chr4:95960149-95960199	HMEC	breast:	n/a
10	chr4:95960149-95960199	HepG2	liver:	n/a
11	chr4:95960149-95960199	GM12891	blood:	n/a
12	chr4:95960149-95960199	AG09319	gingival:	n/a
13	chr4:95960149-95960199	SK-N-MC	brain:	n/a
14	chr4:95960149-95960199	ECC-1	luminal epithelium:	n/a
15	chr4:95960149-95960199	AG10803	skin:	n/a
16	chr4:95960149-95960199	HAEpiC	amniotic membrane:	n/a
17	chr4:95960149-95960199	RPTEC	kidney:	n/a
18	chr4:95960149-95960199	GM06990	blood:	n/a
19	chr4:95960149-95960199	HCF	heart:	n/a
20	chr4:95960149-95960199	GM19239	blood:	n/a
21	chr4:95960149-95960199	NHDF-neo	bronchial:	n/a
22	chr4:95960149-95960199	T-47D	breast:	n/a
23	chr4:95960149-95960199	HIPEpiC	eye:	n/a
24	chr4:95960149-95960199	GM12892	blood:	n/a
25	chr4:95960149-95960199	PFSK-1	brain:	n/a
26	chr4:95960149-95960199	SAEC	small airway:	n/a
27	chr4:95960149-95960199	BJ	skin:	n/a
28	chr4:95960149-95960199	GM12878	blood:	n/a
29	chr4:95960149-95960199	Jurkat	blood:	n/a
30	chr4:95960149-95960199	SK-N-SH	brain:	n/a
31	chr4:95960149-95960199	NH-A	brain:	n/a
32	chr4:95960149-95960199	HCPEpiC	choroid plexus:	n/a
33	chr4:95960149-95960199	MCF-7	breast:	n/a
34	chr4:95960149-95960199	CMK	blood:	n/a
35	chr4:95960149-95960199	HL-60	blood:	n/a
36	chr4:95960149-95960199	SK-N-SH_RA	brain:	n/a
37	chr4:95960149-95960199	PANC-1	pancreas:	n/a
38	chr4:95960149-95960199	HUVEC	blood vessel:	n/a
39	chr4:95960149-95960199	U87	brain:	n/a
40	chr4:95960149-95960199	HRPEpiC	eye:	n/a
41	chr4:95960149-95960199	HPAEpiC	pulmonary alveolar:	n/a
42	chr4:95960149-95960199	AG04450	lung:	fetal
43	chr4:95960149-95960199	ProgFib	skin:	n/a
44	chr4:95960149-95960199	AoSMC	blood vessel:	n/a
45	chr4:95960149-95960199	IMR90	lung:	fetal
46	chr4:95960149-95960199	AG09309	skin:	n/a
47	chr4:95960149-95960199	H1-hESC	embryonic stem cell:	embryo
48	chr4:95960149-95960199	BE2_C	brain:	n/a
49	chr4:95960149-95960199	Caco-2	colon:	n/a
50	chr4:95960149-95960199	NT2-D1	testis:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:95944007..95945865-chr4:95974454..95976433,2	MCF-7	breast:
2	chr4:95966448..95968999-chr4:96005215..96007562,2	MCF-7	breast:
3	chr4:95944191..95946450-chr4:96004489..96006768,3	MCF-7	breast:
4	chr4:95924834..95926933-chr4:95930140..95932231,2	K562	blood:
5	chr4:95924834..95926933-chr4:95930140..95932231,2	K562	blood:
6	chr4:95936185..95937975-chr4:95939110..95940849,2	MCF-7	breast:
7	chr4:95894975..95897109-chr4:95919263..95921019,2	K562	blood:
8	chr4:95936185..95937975-chr4:95939110..95940849,2	MCF-7	breast:
9	chr4:95944007..95945865-chr4:95974454..95976433,2	MCF-7	breast:
10	chr4:95930676..95931407-chr4:96015895..96017114,4	MCF-7	breast:
11	chr4:95961918..95964431-chr4:96005630..96007431,2	MCF-7	breast:

Variant related genes	Relation type
BMPR1B	TF binding region
BMPR1B	CpG island

Extended variants
information (count: 2554 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:2554 , 50 per page) page: 1 2 3 4 5 6 7 ... 52

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6855395	chr4:95917980-95917981	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs535908388	chr4:95917981-95917982	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs549801746	chr4:95917998-95917999	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs542111922	chr4:95918070-95918071	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs575081558	chr4:95918106-95918107	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs563560858	chr4:95918206-95918207	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs538016898	chr4:95918224-95918225	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs182508788	chr4:95918226-95918227	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs577846508	chr4:95918233-95918234	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs544342259	chr4:95918293-95918294	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs377152228	chr4:95918330-95918331	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs575479070	chr4:95918361-95918362	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs34330095	chr4:95918363-95918364	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs145659564	chr4:95918390-95918391	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs114180660	chr4:95918413-95918414	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs573935540	chr4:95918496-95918497	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs542656739	chr4:95918499-95918500	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs545783706	chr4:95918501-95918502	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs562940811	chr4:95918507-95918508	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs189160947	chr4:95918525-95918526	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs528138482	chr4:95918543-95918544	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs545552065	chr4:95918550-95918551	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs546397460	chr4:95918569-95918570	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs565050107	chr4:95918611-95918612	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs138151198	chr4:95918620-95918621	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs547660214	chr4:95918623-95918624	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs561030202	chr4:95918634-95918635	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs76407983	chr4:95918637-95918638	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs549528642	chr4:95918670-95918671	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs114612511	chr4:95918706-95918707	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs4450936	chr4:95918721-95918722	Weak transcription Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs551902392	chr4:95918753-95918754	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs6836504	chr4:95918765-95918766	Weak transcription Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs569204764	chr4:95918776-95918777	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs554395213	chr4:95918807-95918808	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs555078648	chr4:95918835-95918836	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs536612284	chr4:95918838-95918839	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs556579798	chr4:95918879-95918880	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs144296279	chr4:95918925-95918926	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs545515276	chr4:95918937-95918938	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs77701618	chr4:95918957-95918958	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs62316229	chr4:95918993-95918994	Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs193095506	chr4:95919017-95919018	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs35456784	chr4:95919053-95919054	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs561203136	chr4:95919070-95919071	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs529931640	chr4:95919125-95919126	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs543342167	chr4:95919133-95919134	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs562943624	chr4:95919153-95919154	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs184487872	chr4:95919161-95919162	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs551812782	chr4:95919230-95919231	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	18414403	CNVD
primary effusion lymphomas	17116491	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
small cell lung cancer	20016488	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	20459617	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Esophageal cancer	21851588	CNVD
Cancer	19907438	CNVD
Prostate cancer	16573809	CNVD
Multiple myeloma	16616336	CNVD
Myelofibrosis	22110671	CNVD
Pancreatic cancer	17952125	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:465 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:95916600-95918000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr4:95916600-95918000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
3	chr4:95916600-95918000	Enhancers	Fetal Brain Male	brain
4	chr4:95916600-95918600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr4:95916800-95918000	Active TSS	Brain Anterior Caudate	brain
6	chr4:95916800-95918400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr4:95916800-95918600	Active TSS	Psoas Muscle	Psoas
8	chr4:95917000-95918000	Active TSS	Fetal Muscle Trunk	muscle
9	chr4:95917000-95918200	Active TSS	Brain Cingulate Gyrus	brain
10	chr4:95917000-95918200	Active TSS	Skeletal Muscle Male	skeletal muscle
11	chr4:95917000-95918600	Active TSS	Skeletal Muscle Female	skeletal muscle
12	chr4:95917000-95918800	Active TSS	Fetal Muscle Leg	muscle
13	chr4:95917400-95918000	Enhancers	Breast Myoepithelial Primary Cells	Breast
14	chr4:95917400-95918000	Active TSS	Brain Angular Gyrus	brain
15	chr4:95917400-95918000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
16	chr4:95917600-95918000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
17	chr4:95917600-95918000	Enhancers	Primary monocytes fromperipheralblood	blood
18	chr4:95917600-95918000	Active TSS	Brain Hippocampus Middle	brain
19	chr4:95917600-95920600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
20	chr4:95917600-95922600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
21	chr4:95917800-95918000	Enhancers	Aorta	Aorta
22	chr4:95917800-95918000	Enhancers	Fetal Thymus	thymus
23	chr4:95917800-95918000	Flanking Active TSS	Thymus	Thymus
24	chr4:95917800-95918000	Flanking Active TSS	A549	lung
25	chr4:95917800-95918200	Enhancers	Cortex derived primary cultured neurospheres	brain
26	chr4:95917800-95918400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr4:95917800-95918400	Enhancers	Fetal Brain Female	brain
28	chr4:95917800-95920800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr4:95917800-95920800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr4:95917800-95921000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
31	chr4:95917800-95921200	Weak transcription	Muscle Satellite Cultured Cells	--
32	chr4:95917800-95921800	Weak transcription	Fetal Kidney	kidney
33	chr4:95918000-95918200	Active TSS	A549	lung
34	chr4:95918000-95918400	Active TSS	Fetal Thymus	thymus
35	chr4:95918000-95923400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
36	chr4:95918000-95926200	Weak transcription	Thymus	Thymus
37	chr4:95918200-95918600	Enhancers	A549	lung
38	chr4:95918400-95918600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
39	chr4:95918600-95918800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr4:95918600-95919800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr4:95918600-95920600	Weak transcription	Skeletal Muscle Female	skeletal muscle
42	chr4:95918600-95920600	Weak transcription	A549	lung
43	chr4:95918800-95919000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr4:95919000-95920600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr4:95919800-95921800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr4:95920600-95920800	Enhancers	A549	lung
47	chr4:95920600-95921000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr4:95920600-95921000	Enhancers	Skeletal Muscle Female	skeletal muscle
49	chr4:95920600-95921200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
50	chr4:95920800-95921000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links